Treatment for chronic hepatitis B linked to increased rates of colorectal and cervical cancer

A new study demonstrates a potential link between treatment of long-term oral nucleos(t)ide analogues and an increased risk of colorectal (p=0.029) and cervical (p=0.049) cancer in patients with chronic hepatitis B virus (HBV).